June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Single cell RNA sequencing reveals a subtype of pro-angiogenic classical monocyte-derived macrophages during experimental choroidal neovascularization
Author Affiliations & Notes
  • Jeremy Lavine
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Steven Droho
    Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Carla M Cuda
    Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Harris Perlman
    Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Jeremy Lavine None; Steven Droho None; Carla Cuda None; Harris Perlman None
  • Footnotes
    Support  NEI: 1K08EY030923, Research to Prevent Blindness Sybil B. Harrington Career Development Award for Macular Degeneration, BrightFocus Foundation New Investigator Award
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 26. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jeremy Lavine, Steven Droho, Carla M Cuda, Harris Perlman; Single cell RNA sequencing reveals a subtype of pro-angiogenic classical monocyte-derived macrophages during experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 2022;63(7):26.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Macrophages are key pathogenic cells in neovascular age-related macular degeneration. However, macrophages are heterogeneous cells whose function depends upon their microenvironment and/or origin. Choroidal macrophages are derived from blood monocytes, and classical monocyte-derived macrophages (MDMs) are necessary for laser-induced choroidal neovascularization (CNV). We hypothesized that a subtype of classical MDMs stimulates angiogenesis during laser-induced CNV.

Methods : Female wildtype (WT) and Ccr2-/- mice underwent no treatment or laser injury. On Day 3, eyes were harvested, digested into single cell suspensions, and CD45+ cells were isolated by fluorescence-activated cell sorting for single cell RNA-sequencing. Cell Ranger was used for genome alignment and empty droplet exclusion. The data were loaded into Seurat v3 for quality control metrics and cell clustering. Hypergeometric distribution analysis determined which genotype and treatment contributed to each cluster. Differential expression (DE) analysis was performed between each macrophage cluster and all other clusters. GOrilla gene ontology analysis was used to determine the function of each macrophage cluster.

Results : We sequenced 34,215 cells with an average 36,890 reads per cell. We identified 12 total macrophage clusters, including 6 microglia subtypes and 6 macrophage subsets. DE and GO analysis found that only one cluster was enriched for positive regulation of angiogenesis (6.3-fold, q<0.05). DE genes contributing to positive regulation of angiogenesis included Vegfa (vascular endothelial growth factor), Anxa1/2/4/5 (annexins), Il1b (interleukin-1 beta), Fn1 (fibronectin), Mmp12/14 (metalloproteinases), and Spp1 (osteopontin). This Spp1+ cluster was specifically derived from the WT + laser group. In addition, Spp1+ MDMs were enriched for glycolysis and lipid catabolism GO terms, two processes implicated in macrophage-driven angiogenesis. Finally, Spp1+ MDMs specifically express the CD11c receptor.

Conclusions : Spp1+ MDMs express a transcriptome including VEGF and cytokine signaling, matrix metalloproteinases that degrade basement membranes, annexins to increase endothelial sprouting, and fibronectin for scaffolding that stimulates angiogenesis by multiple pathways. Spp1+ MDMs express specific cell surface markers like CD11c, which can be used for therapeutic ablation.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×